Literature DB >> 17053460

Objectives and limitations of bloodless medical care.

Aryeh Shander1, Lawrence T Goodnough.   

Abstract

PURPOSE OF REVIEW: To outline the rationale, limitations, and execution of bloodless medical and surgical programs, highlighting characteristics that contribute to successful outcomes. RECENT
FINDINGS: Clinical experiences with patients who refuse blood transfusions for religious reasons have provided valuable lessons and raise intriguing questions about the necessity of routine blood transfusions. Healthcare centers with bloodless medicine and surgery programs feature a novel concept of patient care aimed at improving outcomes. A one-tiered approach to minimize blood usage for all patients, regardless of religious beliefs, is being successfully adopted at an increasing number of institutions. Since most single blood-conservation techniques reduce blood usage by just 1-2 units, a series of integrated preoperative, intraoperative, and postoperative conservation approaches is required. These include preoperative autologous donation, erythropoietic support, acute normovolemic hemodilution, individualized assessment of anemia tolerance, implementation of conservative transfusion thresholds, meticulous surgical techniques, and judicious use of phlebotomy and pharmacologic agents for limiting blood loss.
SUMMARY: The objectives of bloodless medicine and surgery programs are straightforward but require staff with expertise in transfusion medicine, intensive teamwork, patient-specific customization, careful planning, and integrated use of multimodal strategies.

Entities:  

Mesh:

Year:  2006        PMID: 17053460     DOI: 10.1097/01.moh.0000245692.32085.bd

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  11 in total

1.  Iron therapy: a piece in the puzzle of allogeneic blood saving strategies with a relevant role in patients' blood management.

Authors:  Giancarlo Maria Liumbruno; Daniela Rafanelli
Journal:  Blood Transfus       Date:  2012-01       Impact factor: 3.443

Review 2.  Autologous blood in obstetrics: where are we going now?

Authors:  Giancarlo Maria Liumbruno; Chiara Liumbruno; Daniela Rafanelli
Journal:  Blood Transfus       Date:  2011-10-25       Impact factor: 3.443

3.  Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.

Authors:  Stefania Vaglio; Domenico Prisco; Gianni Biancofiore; Daniela Rafanelli; Paola Antonioli; Michele Lisanti; Lorenzo Andreani; Leonardo Basso; Claudio Velati; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-12-15       Impact factor: 3.443

4.  Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04       Impact factor: 3.443

5.  Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

6.  A new perspective on best transfusion practices.

Authors:  Aryeh Shander; Irwin Gross; Steven Hill; Mazyar Javidroozi; Sharon Sledge
Journal:  Blood Transfus       Date:  2013-01-22       Impact factor: 3.443

Review 7.  Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges.

Authors:  Evan M Bloch; Marion Vermeulen; Edward Murphy
Journal:  Transfus Med Rev       Date:  2011-08-26

Review 8.  Non-blood medical care in gynecologic oncology: a review and update of blood conservation management schemes.

Authors:  Maria Simou; Nikolaos Thomakos; Flora Zagouri; Antonios Vlysmas; Nikolaos Akrivos; Dimitrios Zacharakis; Christos A Papadimitriou; Meletios-Athanassios Dimopoulos; Alexandros Rodolakis; Aris Antsaklis
Journal:  World J Surg Oncol       Date:  2011-11-03       Impact factor: 2.754

9.  Patient blood management in Europe.

Authors:  A Shander; H Van Aken; M J Colomina; H Gombotz; A Hofmann; R Krauspe; S Lasocki; T Richards; R Slappendel; D R Spahn
Journal:  Br J Anaesth       Date:  2012-05-24       Impact factor: 9.166

10.  Survival time in severe hemorrhagic shock after perioperative hemodilution is longer with PEG-conjugated human serum albumin than with HES 130/0.4: a microvascular perspective.

Authors:  Judith Martini; Pedro Cabrales; Ananda K; Seetharama A Acharya; Marcos Intaglietta; Amy G Tsai
Journal:  Crit Care       Date:  2008-04-18       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.